Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesmary Modugno

Showing results (31-40 of 203) with videos related to

Pageof 21
Sort By:
The Journal of Urology|October 12, 2005
Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancerBenjamin Davies, Joseph Chen, Francesmary Modugno, et al.
Gynecologic Oncology|February 10, 2022
Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?Lara S Lemon, Brian Orr, Francesmary Modugno, et al.
American Journal of Obstetrics and Gynecology|October 7, 2004
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosisFrancesmary Modugno, Roberta B Ness, Glenn O Allen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic FracturesKatherine W Reeves, Kimberly Faulkner, Francesmary Modugno, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 8, 2020
Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant ChemotherapyMichelle Heayn, Lauren B Skvarca, Li Zhu, et al.
Oncology|June 10, 2006
Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interactionJoseph M Zmuda, Francesmary Modugno, Joel L Weissfeld, et al.
Gynecologic Oncology|January 26, 2006
Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancerAnna E Lokshin, Mathew Winans, Douglas Landsittel, et al.
Breast Cancer Research and Treatment|February 26, 2008
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal womenAnne McTiernan, LieLing Wu, Vanessa M Barnabei, et al.
Frontiers in Immunology|August 1, 2024
Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascitesLixin Zhang, Mary Strange, Esther Elishaev, et al.
Breast Cancer Research and Treatment|December 11, 2007
Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN)Lesley M Butler, Ellen B Gold, Gail A Greendale, et al.
Pageof 21

Showing results (31-40 of 203) with videos related to

Sort By:
Pageof 21
The Journal of Urology|October 12, 2005
Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancerBenjamin Davies, Joseph Chen, Francesmary Modugno, et al.
Gynecologic Oncology|February 10, 2022
Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?Lara S Lemon, Brian Orr, Francesmary Modugno, et al.
American Journal of Obstetrics and Gynecology|October 7, 2004
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosisFrancesmary Modugno, Roberta B Ness, Glenn O Allen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic FracturesKatherine W Reeves, Kimberly Faulkner, Francesmary Modugno, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 8, 2020
Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant ChemotherapyMichelle Heayn, Lauren B Skvarca, Li Zhu, et al.
Oncology|June 10, 2006
Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interactionJoseph M Zmuda, Francesmary Modugno, Joel L Weissfeld, et al.
Gynecologic Oncology|January 26, 2006
Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancerAnna E Lokshin, Mathew Winans, Douglas Landsittel, et al.
Breast Cancer Research and Treatment|February 26, 2008
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal womenAnne McTiernan, LieLing Wu, Vanessa M Barnabei, et al.
Frontiers in Immunology|August 1, 2024
Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascitesLixin Zhang, Mary Strange, Esther Elishaev, et al.
Breast Cancer Research and Treatment|December 11, 2007
Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN)Lesley M Butler, Ellen B Gold, Gail A Greendale, et al.
Pageof 21